Carl R. Illig

719 citations

21 papers · 499 indexed · h-index 13

Sensory Systems top 10%
Organic Chemistry top 10%
- Click Chemistry and Applications 3
- Synthesis and Biological Evaluation 3
- Synthesis and biological activity 2
- Synthesis and Characterization of Heterocyclic Compounds 2
Toxicology top 10%
Hematology
Genetics
- Coagulation, Bradykinin, Polyphosphates, and Angioedema 3
Oncology
- Peptidase Inhibition and Analysis 6
Molecular Biology
- Chemical Synthesis and Analysis 5
Materials Chemistry
- Lanthanide and Transition Metal Complexes 2

Co-authors: Roger Bone Richard Söll John Spurlino Renée L. DesJarlais Kenneth J. Wilson Christopher J. Molloy Bruce E. Tomczuk Mark R. Player
Cited by: Sensory Systems Organic Chemistry Toxicology
Journals: Journal of the American Chemical Society (1 paper)Journal of Medicinal Chemistry (4 papers)Tetrahedron Letters (1 paper)
Partner nations: United States Belgium

In The Last Decade

Carl R. Illig

21 papers receiving 470 citations

Peers

Countries citing papers authored by Carl R. Illig

Since Specialization

Citations

This map shows the geographic impact of Carl R. Illig's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carl R. Illig with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carl R. Illig more than expected).

Fields of papers citing papers by Carl R. Illig

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carl R. Illig. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carl R. Illig. The network helps show where Carl R. Illig may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Carl R. Illig, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Carl R. Illig Line = papers co-authored together Carl R. Illig links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Discovery of novel potent imidazo[1,2-b]pyridazine PDE10a inhibitors Bioorganic & Medicinal Chemistry Letters ·Sanath K. Meegalla,Hui Huang,Carl R. Illig,Daniel J. Parks,Jinsheng Chen,Yu‐Kai Lee,Kenneth J. Wilson,Sharmila Patel,Wing S. Cheung,Tianbao Lu,Thomas Kirchner,Hossein B. Askari,John G. Geisler,Raymond J. Patch,Alan C. Gibbs,Brian Rady,Margery A. Connelly,Mark R. Player	2016	11
2	Enhancement of kinase selectivity in a potent class of arylamide FMS inhibitors Bioorganic & Medicinal Chemistry Letters ·Carl R. Illig,Carl L. Manthey,Sanath K. Meegalla,Mark J. Wall,Jinsheng Chen,Kenneth J. Wilson,Renée L. DesJarlais,Shelley K. Ballentine,Carsten J. Schubert,Carl Crysler,Yanmin Chen,Christopher J. Molloy,Margery A. Chaikin,Robert R. Donatelli,Edward J. Yurkow,Zhou Zhao,Mark R. Player,Bruce E. Tomczuk	2013	3
3	Reducing ion channel activity in a series of 4-heterocyclic arylamide FMS inhibitors Bioorganic & Medicinal Chemistry Letters ·Kenneth J. Wilson,Carl R. Illig,Jinsheng Chen,Mark J. Wall,Shelley K. Ballentine,Renée L. DesJarlais,Yanmin Chen,Carsten J. Schubert,Robert R. Donatelli,Ioanna P. Petrounia,Carl Crysler,Christopher J. Molloy,Margery A. Chaikin,Carl L. Manthey,Mark R. Player,Bruce E. Tomczuk,Sanath K. Meegalla	2010	9
4	Design and Optimization of Benzimidazole-Containing Transient Receptor Potential Melastatin 8 (TRPM8) Antagonists Journal of Medicinal Chemistry ·Daniel J. Parks,William H. Parsons,Raymond W. Colburn,Sanath K. Meegalla,Shelley K. Ballentine,Carl R. Illig,Na Qin,Yi Liu,Tasha L. Hutchinson,Mary Lou Lubin,Dennis J. Stone,Judith F. Baker,Craig R. Schneider,Jianya Ma,Bruce P. Damiano,Christopher M. Flores,Mark R. Player	2010	59
5	Structure-based optimization of a potent class of arylamide FMS inhibitors Bioorganic & Medicinal Chemistry Letters ·Sanath K. Meegalla,Mark J. Wall,Jinsheng Chen,Kenneth J. Wilson,Shelley K. Ballentine,Renée L. DesJarlais,Carsten J. Schubert,Carl Crysler,Yanmin Chen,Christopher J. Molloy,Margery A. Chaikin,Carl L. Manthey,Mark R. Player,Bruce E. Tomczuk,Carl R. Illig	2008	26
6	Discovery of novel FMS kinase inhibitors as anti-inflammatory agents Bioorganic & Medicinal Chemistry Letters ·Carl R. Illig,Jinsheng Chen,Mark J. Wall,Kenneth J. Wilson,Shelley K. Ballentine,Matthias Rudolph,Renée L. DesJarlais,Yanmin Chen,Carsten J. Schubert,Ioanna P. Petrounia,Carl Crysler,Christopher J. Molloy,Margery A. Chaikin,Carl L. Manthey,Mark R. Player,Bruce E. Tomczuk,Sanath K. Meegalla	2008	40
7	Synthesis and evaluation of novel 3,4,6-substituted 2-quinolones as FMS kinase inhibitors Bioorganic & Medicinal Chemistry Letters ·Mark J. Wall,Jinsheng Chen,Sanath K. Meegalla,Shelley K. Ballentine,Kenneth J. Wilson,Renée L. DesJarlais,Carsten J. Schubert,Margery A. Chaikin,Carl Crysler,Ioanna P. Petrounia,Robert R. Donatelli,Edward J. Yurkow,Lisa Boczon,Marie J. Mazzulla,Mark R. Player,Raymond J. Patch,Carl L. Manthey,Christopher J. Molloy,Bruce E. Tomczuk,Carl R. Illig	2008	45
8	Cyano-Substituted 2-Carboxyimidazoles:Synthesis of 4-Cyano-1-{[2-(trimethylsilyl)ethoxy]methyl}-1H-imidazole-2-carboxylate Potassium Salt Synthesis ·Mark J. Wall,Carsten J. Schubert,Carl R. Illig	2008	2
9	A novel series of potent and selective small molecule inhibitors of the complement component C1s Bioorganic & Medicinal Chemistry Letters ·Nalin L. Subasinghe,Farah Ali,Carl R. Illig,Matthias Rudolph,Scott I. Klein,Ehab M. Khalil,Richard Söll,Roger Bone,John Spurlino,Renée L. DesJarlais,Carl Crysler,Maxwell D. Cummings,Philip E. Morris,John Michael Kilpatrick,Y. Sudhakara Babu	2004	18
10	Design and Synthesis of 4,5-Disubstituted-thiophene-2-amidines as Potent Urokinase Inhibitors Bioorganic & Medicinal Chemistry Letters ·Matthias Rudolph,Carl R. Illig,Nalin L. Subasinghe,Kenneth J. Wilson,James B. Hoffman,Troy L. Randle,David Green,Christopher J. Molloy,Richard Söll,Frank Lewandowski,Marie Zhang,Roger Bone,John Spurlino,Ingrid C. Deckman,Carl L. Manthey,Celia Sharp,Diane Maguire,Bruce Grasberger,Renée L. DesJarlais,Zhou Zhao	2002	23
11	Synthesis of thiophene-2-carboxamidines containing 2-amino-thiazoles and their biological evaluation as urokinase inhibitors Bioorganic & Medicinal Chemistry Letters ·Kenneth J. Wilson,Carl R. Illig,Nalin L. Subasinghe,James B. Hoffman,Matthias Rudolph,Richard Söll,Christopher J. Molloy,Roger Bone,David Green,Troy D. Randall,Marie Zhang,Frank Lewandowski,Zhao Zhou,Celia Sharp,Diane Maguire,Bruce Grasberger,Renée L. DesJarlais,John Spurlino	2001	88
12	Amidinohydrazones as guanidine bioisosteres: application to a new class of potent, selective and orally bioavailable, non-amide-based small-molecule thrombin inhibitors Bioorganic & Medicinal Chemistry Letters ·Richard Söll,Tianobao Lu,Bruce E. Tomczuk,Carl R. Illig,Cynthia L. Fedde,Stephen Eisennagel,Roger Bone,Larry Murphy,John Spurlino,F. Raymond Salemme	2000	33
13	Structure–activity and crystallographic analysis of a new class of non-amide-based thrombin inhibitor Bioorganic & Medicinal Chemistry Letters ·Tianbao Lu,Richard Söll,Carl R. Illig,Roger Bone,Larry Murphy,John Spurlino,F. Raymond Salemme,Bruce E Tomczuk	2000	11
14	1,3,5-Trialkyl-2,4,6-triiodobenzenes: Novel X-ray Contrast Agents for Gastrointestinal Imaging Journal of Medicinal Chemistry ·Kimberly G. Estep,Kurt A. Josef,Edward R. Bacon,Carl R. Illig,John L. Toner,Dinesh Kumar Mishra,William F. Blazak,Dennis M. Miller,David K. Johnson,Jack Allen,Andy Spencer,Susan Wilson	2000	14
15	In vitro evaluation and crystallographic analysis of a new class of selective, non-amide-based thrombin inhibitors Bioorganic & Medicinal Chemistry Letters ·Tianbao Lu,Bruce E. Tomczuk,Carl R. Illig,Roger Bone,Larry Murphy,John Spurlino,F. Raymond Salemme,Richard Söll	1998	20
16	Structural Analysis of Thrombin Complexed with Potent Inhibitors Incorporating a Phenyl Group as a Peptide Mimetic and Aminopyridines as Guanidine Substitutes Journal of Medicinal Chemistry ·Roger Bone,Tianbao Lu,Carl R. Illig,Richard Söll,John Spurlino	1998	21
17	Win 70197: a novel liver-targeted magnetic resonance imaging contrast agent Bioorganic & Medicinal Chemistry Letters ·T.J. Caulfied,Ping Guo,Carl R. Illig,Kenneth E. Kellar,Elaine Liversidge,Jian Shen,Jennifer A. Wellons,David L. Ladd,Nancy Peltier,John L. Toner	1995	5
18	Stereoselective synthesis of (.+-.)-cyanocycline Journal of the American Chemical Society ·David A. Evans,Carl R. Illig,J. C. Saddler	1986	32
19	Nitrone cycloadditions. regiochemistry. Tetrahedron Letters ·Shaikh A. Ali,Pushpananda A. Senaratne,Carl R. Illig,Harold Meckler,Joseph J. Tufariello	1979	9
20	Natural Gas Supplies for Tomorrow Law and Contemporary Problems ·Rex G. Baker,Carl R. Illig	1954	2

About Carl R. Illig

Carl R. Illig is a scholar working on General Energy, Organic Chemistry and Genetics, having authored 21 papers that have together received 499 indexed citations. Recurring topics across this work include Peptidase Inhibition and Analysis (6 papers), Chemical Synthesis and Analysis (5 papers), Click Chemistry and Applications (3 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (3 papers), Synthesis and Biological Evaluation (3 papers), Lanthanide and Transition Metal Complexes (2 papers), Synthesis and biological activity (2 papers) and Synthesis and Characterization of Heterocyclic Compounds (2 papers). The work is most often cited by research in Sensory Systems (46 citations), Organic Chemistry (262 citations) and Toxicology (19 citations). Carl R. Illig has collaborated with scholars based in United States and Belgium. Frequent co-authors include Roger Bone, Richard Söll, John Spurlino, Renée L. DesJarlais, Kenneth J. Wilson, Christopher J. Molloy, Bruce E. Tomczuk, Mark R. Player, Sanath K. Meegalla and Shelley K. Ballentine. Their work appears in journals such as Journal of the American Chemical Society, Journal of Medicinal Chemistry and Tetrahedron Letters.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact